MedPath
HSA Approval

ACOLIC SYRUP

SIN10344P

ACOLIC SYRUP

ACOLIC SYRUP

November 4, 1998

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

A03ED

复方中有其它药物的解痉药

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

Royce Pharma Manufacturing Sdn Bhd

Active Ingredients

SIMETHICONE

50 mg/5 ml

Simethicone

DICYCLOMINE HCl

5 mg/5 ml

Dicyclomine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ACOLIC SYRUP - HSA Approval | MedPath